Skip to main content
SpringerLink
Log in

In Vitro Characterization and in Vivo Testosterone Suppression of 6-Month Release Poly(D,L-Lactide) Leuprolide Microspheres

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. T. Sato, M. Kanke, H. G. Schroeder, and P. P. DeLuca. Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques. Pharm. Res. 5:21–30 (1988).

    Google Scholar 

  2. K. C. Lee, E. E. Soltis, P. S. Newman, K. W. Burton, R. C. Mehta, and P. P. DeLuca. In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres. J. Control. Release 17:199–206 (1990).

    Google Scholar 

  3. G. Hausberger and P. P. DeLuca. Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres. J. Pharm. Biomed. Anal. 13:747–760 (1995).

    Google Scholar 

  4. R. Jeyanthi, R. C. Mehta, B. C. Thanoo, and P. P. DeLuca. Effect of processing parameters on the properties of peptide-containing PLGA. J. Microencapsul. 14:163–174 (1997).

    Google Scholar 

  5. D. A. Puleo, W. W. Huh, S. S. Duggirala, and P. P. DeLuca. In vitro cellular responses to bioerodible particles loaded with recombinant human bone morphogenetic protein-2. J. Biomed. Mater. Res. 41:104–110 (1998).

    Google Scholar 

  6. Y. Capan, B. H. Woo, S. Gebrekidan, S. Ahmed, and P. P. De-Luca. Preparation and characterization of poly (D,L-lactide-coglycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA. Pharm. Res. 16:509–513 (1999).

    Google Scholar 

  7. Y. Capan, B. H. Woo, S. Gebrekidan, S. Ahmed, and P. P. De-Luca. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid. J. Control. Release 60:279–286 (1999).

    Google Scholar 

  8. S. Gebrekidan, B. H. Woo, and P. P. DeLuca. Formulation and in vitro transfection efficiency of poly(D, L-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery. AAPS PharmSciTech. 1:28 (2000) (http://www.pharmscitech.com).

    Google Scholar 

  9. B. H. Woo, J. W. Kostanski, S. Gebrekidan, B. A. Dani, B. C. Thanoo, and P. P. DeLuca. Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres. J. Control. Release 75:307–315 (2001).

    Google Scholar 

  10. K. W. Burton, M. Shameem, B. C. Thanoo, and P. P. DeLuca. Extended release peptide delivery systems through the use of PLGA microsphere combinations. J. Biomater. Sci. Polym. Ed. 11:715–729 (2000).

    Google Scholar 

  11. H. B. Ravivarapu, H. Lee, and P. P. DeLuca. Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Pharm. Dev. Technol. 5:287–296 (2000).

    Google Scholar 

  12. J. Trachtenberg. The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogue. J. Urol. 129:1149–1152 (1983).

    Google Scholar 

  13. N. J. Wojciechowski. Leuprolide: a gonadotropin-releasing hormone analogue for the palliative treatment of prostatic cancer. Drug. Intell. Clin. Pharm. 20:746–751 (1986).

    Google Scholar 

  14. J. L. Cleland. Protein delivery from biodegradable microspheres. Pharm. Biotechnol. 10:1–43 (1997).

    Google Scholar 

  15. H. Okada, Y. Ogawa, and T. Yashiki. Prolonged release microcapsules and their production. US Patent 4,652,441 (1987).

  16. H. Okada, T. Heya, Y. Ogawa, H. Toguchi, and T. Shimamoto. Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate. Pharm. Res. 8:584–587 (1991).

    Google Scholar 

  17. H. Okada, Y. Inoue, T. Heya, H. Ueno, Y. Ogawa, and H. Toguchi. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. Pharm. Res. 8:787–791 (1991).

    Google Scholar 

  18. H. Okada, Y. Doken, Y. Ogawa, and H. Toguchi. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res. 11:1143–1147 (1994).

    Google Scholar 

  19. H. Okada, Y. Doken, Y. Ogawa, and H. Toguchi. Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs. Pharm. Res. 11:1199–1203 (1994).

    Google Scholar 

  20. B. C. Thanoo and J. Murtagh. Continuous microsphere process. US Patent 5,945,126 (1999).

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 90 Rose Street, Lexington, Kentucky, 40536

    Byung Ho Woo, Kyu-Heum Na, Bhas A. Dani, Ge Jiang & Patrick P. DeLuca

  2. Oakwood Laboratories, 7670 First Place-Suite A, Oakwood, Ohio, 44146

    B. C. Thanoo

Authors
  1. Byung Ho Woo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyu-Heum Na
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bhas A. Dani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ge Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. C. Thanoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Patrick P. DeLuca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick P. DeLuca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woo, B.H., Na, KH., Dani, B.A. et al. In Vitro Characterization and in Vivo Testosterone Suppression of 6-Month Release Poly(D,L-Lactide) Leuprolide Microspheres. Pharm Res 19, 546–550 (2002). https://doi.org/10.1023/A:1015168301339

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015168301339

Search

Navigation